POLBF (Poolbeg Pharma) FCF Yield % : -33.21 (As of Apr. 02, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Poolbeg Pharma's Trailing 12-Month Free Cash Flow is $-5.80 Mil, and Market Cap is $17.77 Mil. Therefore, Poolbeg Pharma's FCF Yield % for today is -33.21%.

The historical rank and industry rank for Poolbeg Pharma's FCF Yield % or its related term are showing as below:

POLBF' s FCF Yield % Range Over the Past 10 Years
Min: -33.21 Med: 0 Max: 0
Current: -33.21

POLBF's FCF Yield % is ranked worse than
65.89% of 1498 companies
in the Biotechnology industry
Industry Median: -15.56 vs POLBF: -33.21

Poolbeg Pharma's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Poolbeg Pharma FCF Yield % Historical Data

The historical data trend for Poolbeg Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma FCF Yield % Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

-16.57

-10.03

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial			-13.36	-19.12	-10.30	-9.74	-6.85

Competitive Comparison of Poolbeg Pharma's FCF Yield %

For the Biotechnology subindustry, Poolbeg Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Poolbeg Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Poolbeg Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-5.768	/	57.5
	=	-10.03%

Poolbeg Pharma's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.998	*	2	/	87.5
	=	-6.85%

Poolbeg Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Poolbeg Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

POLB:UK 7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.